【新藥】Merck 將結合《Exscientia》和《BenevolentAI》AI技術，用於癌症、神經病學和免疫學新藥開發
文章出處
Medcity News
原文標題
Merck KGaA Expands in AI-Driven R&D With Two Drug Discovery Deals
Twitter
https://twitter.com/aimedadviser/status/1705023749853233152
文章序號
4367
智醫科學－AI醫療技術、應用與市場動態
Copyright
©2023 智醫科學 MEDai.tw
All rights reserved.
The content of
this site is intended for healthcare and medical professionals.
